Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial | MicrobiomeTrials← Back to trialsNCT07605416
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2027-04-20Est. Completion: 2032-11-06
Enrollment target: 74 participants Locations- UC San Diego Moores Cancer Center, La Jolla, California, United States
- Yale University, New Haven, Connecticut, United States
- Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States
- Our Lady of the Lake Physician Group, Baton Rouge, Louisiana, United States
- Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
- Roswell Park Cancer Institute, Buffalo, New York, United States
- Memorial Sloan Kettering Commack, Commack, New York, United States
- Memorial Sloan Kettering Westchester, Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Other microbiome trials you might be interested in
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaPediatric CancerPediatric ALL, RelapsedPediatric ALLPediatric ALL, B CellAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaPediatric AMLR/R AMLR/R B-cell ALL
The goal of this clinical trial is to learn if sonrotoclax (BGB-11417) is safe and may help treat children and adolescen…
Multiple LocationsEst. completion Apr 30, 2030
Phase 1
Recruiting
Malignancy, HematologicNeoplasms, HematologicNeoplasms, HematopoieticBlood CancerHematological NeoplasmsHematopoietic MalignanciesDysmyelopoietic SyndromesHematopoetic MyelodysplasiaMyeloid Leukemia, AcuteNonlymphoblastic Leukemia, AcuteLeukemia, Lymphocytic, Acute
Background:
Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RA…
Bethesda, United StatesEst. completion Apr 30, 2029
Waldenstrom MacroglobulinemiaLymphoplasmacytic LymphomaMonoclonal B-Cell LymphocytosisSmall Lymphocytic LymphomaCLL (Chronic Lymphocytic Leukemia)
Background
The development of new technologies now allow scientists to investigate the molecular basis and clinical man…
Bethesda, United States